KYTHERA Biopharmaceuticals Announces Closing of Public

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
KYTHERA Biopharmaceuticals Announces Closing of Public Offering and Exercise of Underwriters' Over-Allotment Option

WESTLAKE VILLAGE, Calif., March 16, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq: KYTH ) today announced the closing of its underwritten public offering of 2,994,793 shares of its common stock at a price to the public of $48.00 per share for gross proceeds of approximately $143.8 million, which includes the exercise in full by the underwriters of their option to purchase up to 390,625 shares of common stock. KYTHERA estimates the net proceeds from the offering to be approximately $134.5 million, after deducting underwriting discounts and commissions and expenses of the offering.

Goldman, Sachs & Co., BofA Merrill Lynch, and Leerink Partners acted as the joint book-running managers for the offering. Cowen and Company acted as co-manager.

The offering was made only by means of a prospectus and pursuant to a shelf registration statement declared effective by the Securities and Exchange Commission on November 6, 2014. Copies of the final prospectus and related prospectus supplement relating to the offering may be obtained by contacting Goldman, Sachs & Co., Attention: Prospectus Department, 200 West Street, New York, NY 10282, or by telephone at (866) 471-2526 or e-mail at prospectus-ny@gs.com; or BofA Merrill Lynch, Attention: Prospectus Department, 222 Broadway, New York, NY 10038, or by email at dg.prospectus_requests@baml.com; or Leerink Partners, Attention: Syndicate Department, One Federal Street, 37th Floor, Boston, MA 02110, or by phone at (800) 808-7525, ext. 6142, or by email at syndicate@leerink.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About KYTHERA

KYTHERA Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market. KYTHERA's lead product candidate, ATX-101, is currently in late-stage clinical development as an injectable treatment for the improvement of submental fullness, which commonly presents as a double chin, and is a potential first-in-class submental contouring injectable drug. The FDA has determined the NDA will have a Prescription Drug User Fee Act (PDUFA) action date of May 13, 2015. In addition to its lead product candidate ATX-101, KYTHERA also licensed the worldwide rights to setipiprant, an early-stage potential treatment for hair loss. KYTHERA also maintains an active research interest in fat biology, pigmentation modulation and facial contouring.

Forward-Looking Statements

To the extent that statements contained in this press release are not descriptions of historical facts regarding KYTHERA, they are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve substantial risks and uncertainties that could cause our actual results, performance or achievements to differ significantly from those expressed or implied by the forward-looking statements. KYTHERA undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of the company in general, see the prospectus supplement and accompanying prospectus for this offering included on Form 424(b)(5) as part of the Registration Statement on Form S-3/A filed by KYTHERA on November 6, 2014, as well as KYTHERA's Annual Report on Form 10-K for the year ended December 31, 2014 and its other reports filed with the Securities and Exchange Commission.

Investor Contact: Heather Rowe Director, Investor Relations Tel: (818) 587- 4559

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tessera Delisting Leaves HLSQ in a Tougher Market Ahead

Updated Category News Views 116

November delivered a nasty little truth serum for Tessera Defense and Homeland Security: exchange status is not a cosmetic detail when the stock’s selling price has collapsed. On November 10, NYSE Regulation suspended trading in the company’s common shares on NYSE American and began delisting proceedings. By November 17, Tessera had a chance to request review by the...

Continue Reading
HVAC’s $383.6 Billion Shift Is About More Than Units

Updated Category News Views 163

Server racks are turning cooling gear into a front-row industrial story, and that deserves more attention than the usual sleepy talk about replacement air conditioners. Frost & Sullivan projects the global HVAC equipment market will reach $383.6 billion by 2031, growing at a 7.0% compound annual rate from 2025. That is a sizable market, sure, but the more interesting...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 148

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
Sprocket’s GigaOm Leap Puts PTaaS Claims Under Scrutiny

Updated Category News Views 91

Security vendors love a shiny quadrant, but this one deserves more than the usual polite golf clap. Sprocket Security moved from Challenger and Outperformer in GigaOm’s 2025 Penetration Testing as a Service assessment to a Leader in the version 5 report released in 2026. That is a meaningful jump in a category where buyers are tired of annual testing reports that go...

Continue Reading
Mason Adds Nonprofit Expertise to Institutional Bench

Updated Category News Views 110

Endowment committees rarely need more noise; they need somebody who has actually sat through the uncomfortable votes. Mason Investment Advisory Services has hired Rebecca “Becky” Farnsworth, CFA, as a senior investment consultant, and this looks like a practical addition rather than the usual chest-thumping personnel announcement. Her stated focus will be...

Continue Reading
Childcare Scale Makes Its Case, With Caveats Attached

Updated Category News Views 58

Childcare’s math is brutal before anybody starts arguing over ownership. Families need dependable hours, educators deserve better pay, and operators must keep buildings safe, staffed and open without pricing working parents clean out of the market. That is why this new Tyton Partners review of multi-site providers deserves a fair look, even if nobody should mistake a...

Continue Reading
Shenzhen’s 50-Year Message Carries Real Trade Weight

Updated Category News Views 68

A city once framed as a frontier fishing village is being presented as China’s sharpest recent economic before-and-after picture. At the welcome dinner for the 33rd APEC Economic Leaders’ Meeting in Shenzhen, President Xi Jinping gave guests a compact geographic guide to China’s past: Xi’an for thousands of years, Beijing for 500 years, Shanghai for 100 years, and...

Continue Reading
Digital Diabetes Care Has a Bigger Prize Than Devices

Updated Category News Views 144

A glucose sensor is becoming less a gadget than a running conversation between patient, clinician and software. That shift matters because diabetes management is leaving the occasional clinic visit and moving into daily life, where the useful product is not merely a reading but a pattern someone can act on. The sector deserves attention from investors, but it also...

Continue Reading
Saturn and Tileward Put GPU Memory Back to Work Now

Updated Category News Views 49

GPU memory is the tollbooth nobody notices until the whole AI highway backs up. Saturn Cloud’s new partnership with Tileward goes straight at that constraint: use compressed open-model weights, free memory on hardware already installed, and turn that reclaimed capacity into more tokens that an operator can actually sell. It is not glamorous. It may be one of the more...

Continue Reading
Pennsylvania Housing Finds Its October Holding Pattern

Updated Category News Views 108

Pennsylvania's October housing numbers have the uneasy stillness of a pond before somebody throws a rock. The statewide median sales price sat at $315,000, exactly where it was in September, while sales barely cleared 10,400 and available listings kept inching higher. Nothing in that mix screams boom or bust. Frankly, that is the point: a market can look calm on the...

Continue Reading

Top 5 Most Recently Viewed Articles

AI Data Risks and the Urgent Need for Enhanced Security Measures

Updated Category News Views 233

AI Data Security Threats Revealed by Varonis In a recent study conducted by Varonis, a prominent data security firm, alarming findings have surfaced regarding the vulnerabilities in organizations’ data systems. The report indicates that an overwhelming 99% of businesses have sensitive data that is exposed to artificial intelligence (AI) tools. This raises significant...

Continue Reading
Volt Lithium's Groundbreaking Daily Output Achieved with New Tech

Updated Category News Views 170

Volt Lithium Achieves Remarkable Milestone Volt Lithium Corp. is excited to announce that it has completed a 24-hour continuous run of its Generation 5 Field Unit, achieving an impressive throughput of 11,573 barrels per day. This significant milestone not only exceeds the initial target of 10,000 barrels per day but also demonstrates the company’s rapid advancements in...

Continue Reading
Investors Urged to Act Before PepGen Legal Deadline Approaches

Updated Category News Views 169

Urgent Reminder for PepGen Investors As the deadline approaches, it is vital for affected investors to take immediate action regarding their stakes in PepGen Inc. The renowned law firm, Bragar Eagel & Squire, P.C., is advocating for those who have incurred losses related to their investments in PepGen (PEPG). If you have purchased or otherwise acquired securities in...

Continue Reading
Gaumont's Voting Rights and Share Capital Information Revealed

Updated Category News Views 166

Gaumont’s Recent Disclosure on Voting Rights and Share Capital Gaumont, a well-known name in the film industry, recently shared important details about its voting rights and share capital. This information is crucial for current and prospective investors, providing transparency and clarity regarding the company’s governance structure. Key Details as per Article L....

Continue Reading
EAM-Mosca to Showcase Innovative Packaging Solutions at Expo

Updated Category News Views 170

EAM-Mosca to Showcase Innovative Packaging Solutions at SuperCorr Expo EAM-Mosca is excited to announce its participation in the upcoming SuperCorr Expo, where it will present its latest state-of-the-art strapping and wrapping solutions at Booth #2031. Attendees will have the opportunity to see firsthand how these solutions can improve efficiency and provide enhanced...

Continue Reading